Detection of botulinum neurotoxins

project image


Bangor University


Healthcare and Pharmaceuticals, Life Sciences, Telehealth and Care

About The Opportunity:

Bangor University has developed an assay, which is capable of detecting botulinum neurotoxins.  Currently the toxins are detected by the mouse bioassay; which involves injecting live mice with samples and observing them for symptoms of the disease (botulism) over a number of days. Much focus has been placed on replacing this assay, not only due to the suffering of the animals, but due to the length of the assay and the costs associated with it.

Key Benefits

  • Reduced cost
  • Faster results
  • No need to use animals


  • Rapid diagnosis of botulinum infection

IP Status:

Patent pending


We are looking for collaborative partners to continue development of this technology to refine it and take it to market.  We are particularly interested in engaging with potential licensing partners. 

See more at: